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Modulators
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Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA
Reactive oxygen species (ROS) are widely involved in intracellular signaling and human
pathologies, but their precise roles have been difficult to enumerate and integrate
holistically. The context- and dose-dependent intracellular effects of ROS can lead to
contradictory experimental results and confounded interpretations. For example, lower
levels of ROS promote cell signaling and proliferation, whereas abundant ROS cause
overwhelming damage to biomolecules and cellular apoptosis or senescence. These
complexities raise the question of whether the many facets of ROS biology can be
joined under a common mechanistic framework using computational modeling. Here,
we take inventory of some current models for ROS production or ROS regulation
of signaling pathways. Several models captured non-intuitive observations or made
predictions that were later verified by experiment. There remains a need for systems-
level analyses that jointly incorporate ROS production, handling, and modulation of
multiple signal-transduction cascades.
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INTRODUCTION
Reactive oxygen species (ROS) play a complex role in cellular biology. Initially viewed merely
as harmful byproducts of metabolism, ROS are now known to serve additional functions as
intracellular regulators of various signaling pathways. At low levels, ROS function as a reactive
second messenger mainly by reversible oxidation of key amino acids of target proteins. High ROS
levels, by contrast, cause damage to various biomolecules (lipids, proteins, and DNA) and have
been linked to pathologies including neurodegeneration (Smith et al., 1997; Giasson et al., 2000),
atherosclerosis (Patetsios et al., 2001; Guzik et al., 2006), and renal disease (Nishikawa et al., 2000;
Dounousi et al., 2006). ROS play an especially complex role in cancer, with various oncogenes and
tumor suppressors influencing, and influenced by, the redox environment of the cell (Meng et al.,
2002; Leslie et al., 2003).
It is challenging to study experimentally how endogenous and exogenous sources of ROS are
handled by the cell. In addition, the context- and dose-dependent intracellular consequences of
ROS can result in confounding observations. ROS has been found to stimulate proliferation in
some cell types under certain experimental conditions (Ruiz-Ginés et al., 2000; Nieto et al., 2002)
and inhibit proliferation (Qu et al., 2011) or induce apoptosis (Pierce et al., 1991) in others.
Such contextual and experimental complexities make it difficult to understand ROS holistically
by experimentation alone.
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Computational modeling approaches can tackle this problem
by simulating the concurrent dynamics of many variables,
including those that are difficult to access experimentally (Janes
and Lauffenburger, 2013). Our review here covers the handful
of models described thus far for ROS production and ROS
regulation of signaling pathways (Figure 1). We start with a brief
introduction of ROS, the biological processes that generate them,
and the signaling pathways that sense ROS and detoxify the cell.
We next focus on models that simulate ROS production by the
mitochondria, the predominant intracellular source of ROS, and
by membrane-bound enzymes, which link extracellular signaling
to intracellular ROS production. We also discuss models that
simulate ROS regulation of various signaling pathways, giving a
broader view of the influence ROS have on intracellular signaling.
Finally, we discuss the need for a systems-level analysis of ROS
signaling to provide a generalizable framework that accounts for
the many downstream cellular effects of ROS.
ROS: SOURCES, SCAVENGERS, AND
EFFECTORS
Reactive oxygen species are chemically reactive species derived
from the incomplete reduction of oxygen. Common examples
are hydrogen peroxide (H2O2), superoxide (O−2 ), and hydroxyl
radicals (HO·). For most cell types, ROS production mainly
occurs through mitochondrial oxidative phosphorylation.
Inherent leakiness of the electron transport chain (ETC),
specifically from complex I and complex III, causes some
electrons to flow out of the pathway and partially reduce oxygen
to the superoxide anion. Other endogenous sources of ROS
include the membrane-bound enzyme NADPH oxidase, which
produces ROS in response to various ligands, along with other
enzymes such as xanthine oxidase, cyclooxygenases, and nitric
oxide synthase. To detoxify excess ROS, cells are equipped with
antioxidants, including the thiols glutathione and thioredoxin,
which are regulated by the transcription factor NRF2 (Itoh
et al., 1997; Chorley et al., 2012). Tight regulation of ROS by
antioxidant systems is necessary to balance the generation of
ROS and to curtail oxidative damage to biomolecules.
CHALLENGES OF MEASURING ROS
Reactive oxygen species are difficult to measure reliably within
cells. For example, early measurements of cellular oxidative
state used dyes such as 2′,7′-dichlorofluorescin (DCFH) which
were later shown to create additional radical species (Rota
et al., 1999). The secondary reactions and instability of the dye
made long-term imaging with DCFH impossible. To address
these deficiencies, researchers engineered fluorescent reporter
proteins such as HyPer, RoGFP, and RxYFP (Hanson et al., 2004;
Belousov et al., 2006; Meyer and Dick, 2010), which undergo
redox-sensitive conformational changes that elicit a change in
fluorescence. Genetically encoded fluorescent proteins enable
live-cell imaging and are further capable of localizing ROS
production to specific sub-cellular compartments (Malinouski
et al., 2011; Swain et al., 2016). Nevertheless, these sensors might
miss low concentrations of H2O2 due to the endogenous enzyme
peroxiredoxin, which is ∼100-fold more active toward H2O2
compared to introduced probes (Ezerin¸a et al., 2014).
Given these challenges, some groups have taken a more
computational approach to calculating the kinetics associated
with H2O2 (Brito and Antunes, 2014). Lim et al. built a reaction-
diffusion model to study localization of H2O2, which is important
for control and specificity of redox signaling. They incorporated
cytoplasmic diffusion into their reduced kinetic model of H2O2
clearance, in which peroxiredoxin is the dominant scavenging
molecule (Lim et al., 2015). Using modeled concentration profiles
obtained after bolus addition of H2O2 to the extracellular
medium, the authors determined order-of-magnitude estimates
for intracellular H2O2 diffusion through the cytosol, with a length
scale of 4 µm and a time scale of 1 ms (Lim et al., 2016). The short
length scale and rapid time scale indicate that H2O2 degradation
and signaling are localized to the area where H2O2 is produced,
contradicting the common modeling assumption of a well-mixed
cytoplasm. This finding could explain discrepancies observed
between bolus addition versus steady intracellular generation of
H2O2 (Sobotta et al., 2013; Cheong et al., 2015). Rapid H2O2
scavenging also has implications for intracellular signaling, as
H2O2 reactivity is limited to molecules in the subcellular vicinity.
ROS PRODUCTION BY COMPLEX III OF
THE ETC
Physiologically, ROS production increases under hypoxic
conditions. Hypoxia causes a decrease in the maximum reaction
rate of complex IV, which is thought to cause excess electron
leakage from other components of the ETC, such as complex III
(Chandel et al., 2000). After a return to normoxic conditions,
ROS remain at higher hypoxic levels. The stable switch in
ROS production is relevant during organ transplantation
and other surgeries requiring an ischemic period. To better
understand the mechanism behind this bistability, Selivanov
et al. (2009) modeled the Q cycle mechanism of Complex III in
the mitochondrial respiratory chain as the primary mechanism
of ROS generation. Complex III can take on as many as 400 redox
states due to its binding to quinones. The authors elaborated a
system of differential equations describing the evolution of all
of the redox states of Complex III. Model simulations predicted
that Complex III can exist in two different steady states, a low
ROS-producing state and a high ROS-producing state. This
bistability is dependent upon the initial conditions of the system,
specifically the redox state as predicted by levels of semiquinone
and free ubiquinol. If starting in a highly reduced state, the
overall system remains reduced, whereas if it starts in a less
reduced state, Complex III progresses to a steady state with low
semiquinone concentration and thus low ROS production. The
overall system evolves to the high ROS producing state either
by an increase in succinate concentration, causing the reduction
of ubiquinone to ubiquinol, or a decrease in oxygen content.
Once switched to this high ROS-producing state, Complex
III persists in that state even after a return to lower succinate
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FIGURE 1 | Computational models of reactive oxygen species (ROS) production and signal-transduction modulation.
concentration or normoxic conditions. The sustained increase in
ROS production provides a mechanism that may contribute to
reperfusion injury after ischemia.
The model predictions were experimentally validated in
isolated rat brain mitochondria incubated with succinate with
or without the addition of ADP. The addition of ADP,
and subsequent synthesis of ATP, switches mitochondria to
a low ROS-producing state and thereby lowers mitochondrial
membrane potential. Once all the ADP is consumed, membrane
potential increases to pre-ADP levels, but ROS production
remains at the lower initial level. These results agree with model
predictions that two levels of ROS production could coexist
under the same set of parameters and give rise to metabolic
heterogeneity in an isogenic population of cells.
ROS PRODUCTION BY COMPLEXES I
AND III OF THE ETC
Reactive oxygen species are also produced by Complex I of the
ETC. Gauthier et al. (2013a) built a computational model of
the ETC focusing on ROS production by both complex I and
III (Figure 1). Simulations were used to study the control of
ROS production in cardiac myocytes under different metabolic
conditions. The model is composed of non-linear ordinary
differential equations describing the oxidation states of the
various forms of ubiquinone, produced by complex I electron
transfer, and the three subunits of complex III: cytochrome
b, cytochrome c1, and the iron sulfur protein. The authors
investigated how mitochondrial membrane potential, matrix pH,
and ROS scavenging affect ROS production and control. When
membrane potential increased 20 mV higher than unstressed cells
to above ∼150 mV (Padmaraj et al., 2014), the model predicted
that complex III ROS production as a function of membrane
potential switches from zeroth order (constant production)
to first order (exponential production). Increased membrane
potential leads to a reduction in the Q cycle reaction rate, or
conversion of ubiquinol to ubiquinone, causing a substantial
increase in ROS production rate.
The model predictions agree with experimental results
reporting a threshold membrane potential of 153 mV, above
which ROS production increases dramatically (Korshunov
et al., 1997). When simulating an increase in mitochondrial
matrix pH, the model predicted that ROS production
from complexes I and III increases during forward electron
transport. This pH-dependent mechanism of ROS generation
was experimentally observed by Selivanov et al. (2008)
who found that an increase in pH from 6 to 7 caused a
threefold increase in ROS production rate. During reverse
electron transport, where electrons flow toward complex I
in the presence of a weak reducing agent, complex I ROS
production also increased with matrix alkalinization. The
model therefore correctly predicted the dependence of ROS
production on both mitochondrial membrane potential and
matrix pH.
ROS levels are governed not only by production, but
also by clearance through scavenging mechanisms. To gain
a more complete picture of ROS dynamics, Gauthier et al.
added glutathione and thioredoxin-mediated ROS scavenging
mechanisms to the model (Aon et al., 2012). ROS production
decreased to a minimum level as the mitochondrial environment
became more oxidized and then rose again as the scavenging
systems became depleted. This result agrees with the redox-
optimized ROS balance hypothesis (Aon et al., 2010), which
states that ROS levels are lowest at an intermediate mitochondrial
redox potential. Together, the authors’ minimal model of ROS
regulation produced results that matched many independent
experiments describing different regimes of ROS production,
providing support for the hypothesis that the cellular redox state
influences the rate of ROS production.
Applying their model, Gauthier went on to investigate
ROS production and scavenging in the context of heart
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failure (Gauthier et al., 2013b). Integrating the ETC-ROS
model discussed above into a mitochondrial energetic-redox
model (Kembro et al., 2013) allowed the authors to test the
hypothesis that mitochondrial Ca2+ mismanagement leads to
high levels of ROS during heart failure. In agreement with
this hypothesis, their model showed that under conditions
of mismanaged mitochondrial Ca2+, NADH levels decrease
drastically under simulated cardiac pacing, highlighting the
link between compromised Ca2+ and NADH regulation. Lower
amounts of NADH lead to lower NADPH levels and a decreased
ability to reduce scavenging enzymes for reuse, causing ROS to
accumulate. ROS levels in mitochondria increase under increased
load (Satapati et al., 2015), but surprisingly the model predicted
that ROS production actually decreases under these conditions.
The net increase in ROS abundance stems from an even-further
reduction in ROS scavenging, which causes ROS accumulation in
the cell. Therefore, in the setting of heart failure, preservation or
restoration of scavenging enzymes may prove more effective than
efforts to block ROS production (Linke et al., 2005).
In another model of ROS production by ETC complexes I
and III, Bazil et al. (2016) described ROS generation by oxidative
phosphorylation coupled to ATP demand. They updated an
existing kinetic model of oxidative phosphorylation (Beard,
2005) to include ROS generation by complexes I and III and
first-order scavenging by superoxide dismutase and peroxidase.
Model simulations agreed with previous findings that free radical
production by complex III is higher than complex I production
under physiological conditions (Gauthier et al., 2013a). As
ATP demand increases, the steady state production of ROS
also increases, in line with experimental observations (Liu,
2010). The authors further applied their model to study reverse
electron transport that is seen during reperfusion. Simulating
ischemia/reperfusion led to bistability in ROS production
(Selivanov et al., 2009, 2011) only when the activity of complex
II was increased. Complex II activity requires electrons to
be supplied to the quinone pool by the dehydrogenation of
succinate to fumarate. The predicted importance of complex
II agrees with work by Chouchani et al. (2014) showing that
succinate is a main driver of mitochondrial ROS production
upon reperfusion (Chouchani et al., 2014). Therefore, complex
II inhibition during reperfusion could prove useful to decrease
ROS production and reperfusion injury (Valls-Lacalle et al.,
2016).
ROS PRODUCTION BY THE
MITOCHONDRIAL NETWORK
In a phenomenon known as ROS-Induced ROS Release (RIRR),
damaged mitochondria produce an increased amount of ROS,
which causes surrounding mitochondria to increase ROS
production through a positive-feedback loop. Park et al. (2011)
used an agent-based model describing inter-mitochondrial
signaling to study the role of mitochondrial network dynamics
in mitochondria-driven ROS production (Figure 1). Simulations
were performed with three different mitochondrial networks:
uniformly distributed mitochondria, as seen in cardiomyocytes;
irregularly distributed mitochondria, as in neurons; and sparsely
distributed mitochondria, as found in white blood cells (Maianski
et al., 2004). The simulations introduced hydrogen peroxide
as an initial oxidative stress, causing mitochondria in the
surrounding area to produce more ROS. Mitochondrial ROS
diffuse stochastically by random walk in 2D space, amplifying
the local ROS response. Depending on the initial oxidative
stress insult and the mitochondrial network dynamics, ROS
production is blocked by antioxidant enzyme systems or becomes
amplified by RIRR, which propagates ROS through the entire
cell. The goal of the model was to predict the percent reactive
mitochondria resulting from an initial oxidative stress input
and the initial hydrogen peroxide concentration that causes
RIRR.
The model indicated that ROS propagation is faster in
the cardiomyocyte model than in the irregular distribution
model, as shown by a higher dose dependence of reactive
mitochondria as a function of initial oxidative stress. In
addition to mitochondrial distribution, the model predicted that
the density of mitochondria affects the response to oxidative
stress inputs. Cells with a low density of mitochondria have
considerable ROS propagation after low levels of oxidative
stress, while cells with a high density of mitochondria only
show strong ROS propagation after high levels of oxidative
stress. The authors hypothesized that these differing responses
to oxidative stress are due to differences in ROS signal
transduction between mitochondrial networks. They further
simulated the addition of different antioxidants to find that
superoxide-scavenging antioxidants block ROS propagation
more effectively in the cardiomyocyte model, while antioxidants
that detoxify hydrogen peroxide are more effective in the
irregular-distribution and low-density models of mitochondria.
These results suggest that mitochondrial network configuration
influences which molecular species is used to propagate ROS in
the cell.
ROS PRODUCTION IN RELATION TO
ANTIOXIDANT SIGNALING
Cyclosporin A (CsA) is an immunosuppressant, which indirectly
causes oxidative stress (Parra Cid et al., 2003) and adaptively
activates the NRF2 pathway in the kidney. Hamon et al. (2014)
fused an in vitro pharmacokinetic model (Wilmes et al., 2013)
of CsA distribution in cultured renal epithelial cells with a
dynamical model of NRF2 signaling originally designed to
capture the cellular response to xenobiotics (Zhang et al., 2009).
The authors adapted the NRF2 model to accommodate ROS
as a state variable generated in proportion to cytosolic CsA
(Hamon et al., 2014). In the revised model, ROS are detoxified
by glutathione peroxidase and further act as an oxidant and
inhibitor of KEAP1, which degrades NRF2. Last, CsA was
forbidden from interacting with the aryl hydrocarbon receptor
as xenobiotics do in the original model, because experimental
data was lacking for such an interaction. To parameterize
the fused model, Bayesian inference was used together with
transcriptomic, proteomic, and metabolomic data collected from
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cells treated with different concentrations of CsA dosed daily
for 2 weeks. The model predicted that low doses of CsA
yielded widespread oscillations throughout the network as cells
metabolized the administered CsA and detoxified ROS before
the next administration. At high doses, however, the cell is
overwhelmed and the modeled network locks into an elevated
state of ROS adaptation. These predictions were not followed up
experimentally, but the work of Hamon et al. (2014) nonetheless
illustrates how toxicologic models can be repurposed for ROS
specifically.
ROS PRODUCTION IN THE
PHAGOSOME MEMBRANE BY NADPH
OXIDASE
Aside from the ETC, ROS also play a key role in pathogen
clearance. Neutrophils utilize ROS to attack bacteria engulfed
within a phagosome. The source of this ROS burst is
not from mitochondrial respiration but from the NADPH
oxidase complex at the plasma membrane (Henderson and
Chappel, 1996) (Figure 1). Levels of ROS oscillate in the
neutrophil (Wymann et al., 1989); however, the mechanism
behind these oscillations was unclear. Olsen et al. (2003)
proposed that the oscillations arose from interactions among
myeloperoxidase, melatonin, NADPH, and NADPH oxidase. To
explore the oscillatory behavior, they built a two-compartment,
differential equation model of the phagosome and the cytoplasm
(Olsen et al., 2003). Without NADPH oxidase activity, model
simulations exclusively produced damped oscillations that
converged to a steady-state; by contrast, addition of NADPH
oxidase elicited sustained oscillations similar to those reported
experimentally (Petty, 2001). The authors triggered ROS
oscillations in neutrophils with the activating chemotactic
peptide FMLP and showed that pre-incubation with an
inhibitor of NADPH oxidase blocked oscillations. Their model
further predicted that melatonin would change the amplitude
of the ROS oscillations measured. Pre-incubation of FMLP-
activated neutrophils with melatonin confirmed the predicted
increases in ROS amplitude. Computational and experimental
modeling of NADPH oxidase in this setting allowed the
authors to understand the basis of melatonin “priming”
previously observed in neutrophils (Recchioni et al., 1998),
underlining the power of pairing in silico and in vitro
experiments.
ROS PRODUCTION DURING
WNT/β-CATENIN SIGNALING
Reactive oxygen species are also generated as a secondary
byproduct of multiple signal transduction cascades (Meier
et al., 1989; Thannickal and Fanburg, 1995). Haack et al.
(2015) built a model of the WNT/β-catenin signaling pathway
that included membrane-related processes as well as ROS
signaling. The authors sought to explain experimental
results showing that disruption of membrane lipid rafts
inhibits WNT/β-catenin signaling, and also that ROS activate
WNT signaling in the context of differentiation of human
neural progenitor cells (Funato et al., 2006; Rharass et al.,
2014). The three-compartment model is based on mass-
action kinetics and includes: a membrane model, in which
WNT binds to receptor LRP6 causing its phosphorylation
within lipid rafts; an intracellular model, in which AXIN
binds phosphorylated LRP6 to prevent degradation of β-
catenin; and a redox model, in which ROS increase the
concentration of DVL-bound AXIN, making AXIN unable
to degrade β-catenin. Simulations were initiated with a
burst of ROS that was shown experimentally to coincide
with the beginning of neural progenitor differentiation
induced by growth-factor withdrawal. The model predicted
an immediate, transient β-catenin stabilization resulting
from redox-dependent DVL/AXIN binding, followed by
a sustained β-catenin response arising from lipid raft-
dependent canonical WNT signaling. The immediate
β-catenin accumulation was observed experimentally by
the authors in lipid raft-deficient cells that maintained a
transient β-catenin response. By including ROS signaling, the
extended WNT/β-catenin signaling model correctly captured
experimental β-catenin nuclear dynamics during early neuronal
differentiation.
ROS MODULATION OF IL-4 SIGNALING
Dwivedi et al. (2015) looked at modulation of cell signaling
by ROS in another setting, using the IL-4 signaling pathway
as a redox-regulated case study. The authors sought to identify
the most important mechanisms of redox regulation in the
IL-4 pathway, which is important for regulating the effector
T-cell response. The activated IL-4 receptor complex upregulates
ROS through NADPH oxidase (Sharma et al., 2008), which
influences signal transduction that proceeds through JAKs and
culminates in the phosphorylation of STAT6. To identify the
combination of regulatory mechanisms that best recapitulated
the dynamics of IL-4 induced STAT6 phosphorylation, the
authors turned to Monte Carlo analysis of an IL-4 ordinary
differential equation model. Phosphorylated STAT6 dynamics
were best captured by a model that incorporated a protein
tyrosine phosphatase whose activity and nucleocytoplasmic
shuttling were ROS sensitive. ROS regulation of phosphatase
activity and localization, along with other ROS-independent
mechanisms, were included in the systems-level model of
IL-4 signaling, with parameters fit to experimental data in
IL-4-stimulated Jurkat cells. The model predicted diminished
STAT6 phosphorylation following IL-4 stimulation and ROS
inhibition, which was confirmed experimentally by NADPH
oxidase inhibition of IL-4-stimulated cells. Transient oxidation of
protein tyrosine phosphatases was also observed experimentally
by oxidized protein tyrosine phosphatase immunoprecipitation
of extracts from IL-4-stimulated Jurkat cells. The authors’
systems-level model provides a framework for investigating
additional modes of receptor-initiated oxidation not previously
explored.
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ROS CROSSTALK WITH INSULIN
SIGNALING
Smith and Shanley (2013) adapted an existing differential
equation model of insulin signaling (Sedaghat et al., 2002)
to incorporate ROS and study the interplay between insulin
signaling and oxidative stress (Figure 1). Insulin-stimulated ROS
production was assumed to occur through activation of NADPH
oxidase and is about fivefold higher than the background
level of mitochondrially produced ROS (Mahadev et al., 2001).
ROS deactivate the phosphatases PTEN and PTP, activate
the kinases JNK and IKK, and are detoxified by cytoplasmic
SOD2. This model was used to make predictions about ROS,
FOXO, SOD2, and insulin receptor abundances over long time
scales.
When hydrogen peroxide was added as an oxidant to the
system with or without insulin stimulation, the model predicted
surprisingly different responses. Hydrogen peroxide alone caused
modest glucose uptake and insulin alone caused strong glucose
uptake, but hydrogen peroxide and insulin stimulation together
were antagonistic, causing only moderate glucose uptake. In
the model, this dampening effect of oxidative stress occurs
because hydrogen peroxide and insulin together activate protein
kinases (e.g., JNK, IKK), which cause hyperphosphorylation of
IRS1 and decrease its ability to form the IRS1-PI3K complex
that stimulates glucose uptake. The model also predicted that
the FOXO-mediated antioxidant response depends critically on
the extent of oxidative stress. With low oxidative stress, the
antioxidant enzyme SOD2 is upregulated by FOXO through
a JNK-mediated mechanism, but SOD2 is downregulated at
higher levels of stress through an IKK-mediated mechanism.
Although simplified in its handling of ROS and antioxidant
pathways, this integrated systems model captures some of the
complexities of oxidative stress for an important metabolic
pathway.
ROS PRODUCTION AS ONE NODE IN A
LARGER NETWORK OF CARDIAC
FIBROBLAST SIGNALING
The previously discussed models incorporated ROS into a
single canonical signaling pathway, but the generation and
handling of ROS pervades multiple pathways and can lead
to counterintuitive cell outcomes (Wang et al., 2011). Zeigler
et al. (2016) incorporated ROS as part of a much larger
signaling network to identify regulators of cardiac fibrosis.
A cardiac fibroblast signaling network was designed to study
drivers of fibrosis, which is implicated in many cardiac
pathologies (Moreo et al., 2009). The network was compiled
from experimental data on 10 pathways that are known
to be important in cardiac injury, such as the IL-1 and
TGFβ pathways. The model was formed using a logic-
based differential equation approach (Kraeutler et al., 2010),
whereby species are represented as differential equations with
rates of change dictated by Hill functions and truth tables
comprised of interacting biomolecules. ROS production is
controlled by the activity of NADPH oxidase and feeds into
the truth tables of JNK and ERK activation, linking ROS
generation at the plasma membrane to downstream intracellular
responses.
In the model, reducing ROS levels had far-reaching and
context-dependent effects on the network. Under baseline
conditions, reductions in ROS caused a decrease in matrix
metalloproteinase 9 (MMP9), which is important for
the breakdown of extracellular matrix. By contrast, in an
environment with high TGFβ signaling, like in a myocardial
infarction, reducing ROS led to an increase in MMP9 activity.
Therefore, a therapeutic prediction of the model is that
antioxidant treatment for fibrosis would be more beneficial in
the high TGFβ environment of myocardial infarct.
CONCLUSION AND FUTURE OUTLOOK
The computational models of ROS biology covered in this
review largely focus on ROS handling within the cell or on
ROS modulation of canonical signaling pathways. In the future,
we anticipate more sophisticated models that combine ROS
handling and signaling concurrently. A prime test bed for such
an integrated approach would be the NF-κB pathway, which is
activated by ROS (Schreck et al., 1991) and is responsible for
inducing scavenging enzymes such as SOD2 (Wong and Goeddel,
1988). Finn and Kemp (2012) have assembled a provisional
model of IKKβ S-glutathionylation in the setting of antioxidants
and chemotherapy-induced ROS. The coupling of signaling,
production, and scavenging could give rise to feedback networks
that explain the variable oxidative stress observed in some
settings among single cells in very similar microenvironments
(Wang et al., 2011).
There is also a need to build multiscale models that
place ROS in the broader context of developing tissues,
tumors, and infections (Schwarz, 1996; Bajikar and Janes,
2012; Wang et al., 2012). The dynamics of proliferation
and death impinge on metabolism and signal transduction,
which culminate to impact the redox state of cells in the
population. Crosstalk between these cellular pathways may
require different classes of modeling than those implemented
so far (Anderson et al., 2006; Chitforoushzadeh et al.,
2016). Advances in measurement will likewise expand
the scope of targets modified by ROS (Kim et al., 2015)
and reveal the extent to which molecular crosstalk is
underappreciated.
Integration of ROS signaling into larger networks may
allow researchers to predict outcomes of drug treatments that
affect ROS generation, which causes drug resistance in some
cancer contexts (Nieborowska-Skorska et al., 2014; Okon et al.,
2015). A deeper understanding of ROS network dynamics could
generate combinatorial treatments that avoid neutralizing drug
efficacy. In the broader human population, there are many
polymorphisms that affect ROS generation and scavenging, such
as p22phox C242T and SOD2 A16V (Bresciani et al., 2013; Meijles
et al., 2016). These variants may tune how ROS interacts with
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other signaling networks, contributing to heterogeneous patient
responses during therapy.
ROS are a fact of life that cannot be ignored. Like a
living cell, investigators must find ways to deal with ROS
holistically and achieve our goals despite their presence.
The tools for pharmacologic modulation of ROS are
predominantly limited to antioxidants. Systems modeling of
ROS may one day provide a venue for exploring more-precise
interventions that account for the complex biological processes
involved.
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